By Simon J Gaskell, Director of the Michael Barber Centre for Mass Spectrometry in the School of Chemistry and the Manchester Interdisciplinary Biocentre and Isabel Riba-Garcia, Research Fellow, Michael Barber Centre.
By Werner Stuermer, Altana Pharma
By Carlo E.A. Jochems and Stefan Herzig, Department of Pharmacology, Faculty of Medicine, University of Köln
By Graham Cook Ph.D., Director Technology and External Supply, EMEA, Wyeth
By Bart Hazes, Dept. of Medical Microbiology & Immunology, University of Alberta and Bernhard Rupp, q.e.d. life science discoveries, inc.
By Jinghai J. Xu, Ph.D., Margaret C. Dunn, Arthur R. Smith, Pfizer Global Research and Development
By Tony Cundell, Director, Pharmaceutical Sciences – Microbiology, Schering Plough Research Institute
By Dr Danielle Giron, President, Swiss Society for Thermal Analysis & Calorimetry
By Michael E. Burczynski, Ph.D. and Ole E. Vesterqvist, Ph.D. Biomarker Laboratory, Clinical Translational Medicine, Wyeth Research
By Dr Yan Sun, MitoCheck Project Manager, Institute of Molecular Pathology
By Sakari Kauppinen, Joacim Elmen and Phil Kearney, Santaris Pharma
By Dr Anne Katrin Werenskiold, Project Manager, Interaction Proteome
By Dr Lorenz M. Mayr, Executive Director & Head Biochemical Screening and Dr Hartmut Zehender, Labhead SpeedScreen, Biochemical Screening, Novartis Institute for Biomedical Research
By Dolores Diaz, CEREP and Peter J. O’Brien, Safety Sciences Europe, Pfizer Global R&D